Stabilita Competitors

At the intersection of technology, data science, and healthcare, Verily Health transforms complex health data into trusted intelligence, enabling health solutions that are more personal, predictive, and precise. Verily’s flagship Governed Health Intelligence platform, Verily Pre, enables healthcare organizations to responsibly govern, model, and securely activate their protected health data at scale, deploying intelligence with the scientific rigor, oversight, and auditability needed for healthcare. For more information about Verily Health, please visit verily.com. Verily is hiring! Check out what's available globally at verily.com/careers.

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

mySugr specializes in app-based, all-around care for people with diabetes made by people with diabetes. Our digital diabetes solution combines diabetes coaching, therapy management, diabetes supplies, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes. mySugr creates simple, effective solutions that serve people with diabetes, as well as organizations that manage populations with diabetes.